Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GUT3D-PLATE

Financiado

Cerrado

Ready to use cell culture plates for gut 3D models

3D cell culture models are considered the next-generation in vitro models. Several efforts are being devoted to better mimic human physiology and predict drug efficacy. In case of the intestinal tissue models, the 3D architecture... ver más

30/06/2022

FUNDACIO INSTITUT...

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUN... Otra investigación y desarrollo experimental en ciencias naturales y técnicas asociacion

TRL 4-5 | 50K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-06-30

ERC-2019-POC: ERC Proof of Concept Grant

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

FUNDACIO INSTITUT DE BIOENGI...

150.00K€ | Lider

VALEO TERMICO

1.13M€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TechTissue TechTissue - Validate human-based 3D in vitro models for acc... 75K€ Cerrado

AnisoPlate High-throughput production of anisotropic 3D human tissue mo... 150K€ Cerrado

SILKink Revolutionary silk-based bioink for 3D printing of ex vivo b... 2M€ Cerrado

PDC2022-133704-I00 PROTOTIPO DE BIOREACTOR DE FIBRA HUECA MICROPOROSA AVANZADA... 138K€ Cerrado

FJC2021-047698-I Bioresorbable materials to manufacture scaffolds for biomedi... 65K€ Cerrado

PGC2018-097323-A-I00 FABRICACION DE ALTO RENDIMIENTO DE DISPOSITIVOS BIOMECATRONI... 67K€ Cerrado

Duración del proyecto: 27 meses Fecha Inicio: 2020-03-09
Fecha Fin: 2022-06-30

Líder del proyecto

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUN... Otra investigación y desarrollo experimental en ciencias naturales y técnicas asociacion

TRL 4-5 | 50K€

Presupuesto del proyecto 150K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto 3D cell culture models are considered the next-generation in vitro models. Several efforts are being devoted to better mimic human physiology and predict drug efficacy. In case of the intestinal tissue models, the 3D architecture of the intestinal tissue and the soft mechanical properties have been identified as key factors to obtain models with improved predictive capacities. However, there is a lack of low-cost and ease-to-use intestinal tissue models that encompass both elements. In the COMIET ERC project, we developed 3D cell culture scaffolds that accurately mimic the villus and crypt morphologies of the human intestine using soft materials. We used an innovative light-based approach to fabricate hydrogel scaffolds with the proper dimensions and mechanical properties of the tissue, in a reproducible manner. This ERC PoC GUT3D-PLATE will develop further the technology and customize a 3D low cost printing device to be able to fabricate ready-to-commercialize 3D cell culture substrates mimicking the intestinal physiology. These substrates will be provided as ready-to-use cell culture inserts, compatible with conventional assays and without the need of specialized equipment. The scaffolds support the growth of conventional intestinal cell lines and primary-derived cells and can be used as platforms for drug screening, disease modeling and microbiome interactions. GUT3D-PLATE will also explore the commercial feasibility of the product by protecting the IPR, analyzing the market, and designing a business plan that provides the roadmap to attract investors. The intestinal 3D culture models will be attractive not only to the biomedical research community, but also to the pharma industry and CROs as they are increasingly investing in tools that better predict drug treatment efficacy and toxicity at early stages of the drug development process. This will reduce significantly the need for animal models and the overall cost, generating a major societal benefit.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores